Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation.
Tamaki
H
H
Ogawa
H
H
D014408:Biomarkers, Tumor / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000628:therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis*; D014184:Transplantation, Homologous; D025721:WT1 Proteins / Q000235:genetics*
D014408:Biomarkers, Tumor; D025721:WT1 Proteins